Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population

Jacob C Jentzer1,2, Sabri Soussi3,4, Patrick R Lawler5,6

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Insights

This study validates cardiogenic shock (CS) phenotypes in a cardiac intensive care unit (CICU) population. Identified clusters showed a clear gradient in mortality, improving risk stratification beyond current measures.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Machine Learning in Healthcare

Background:

  • Unsupervised machine learning identified distinct phenotypes in cardiogenic shock (CS) populations.
  • Validation of these phenotypes in a mixed cardiac intensive care unit (CICU) population is crucial for clinical application.

Purpose of the Study:

  • To validate previously proposed CS phenotypes in a real-world CICU patient cohort.
  • To assess the association of these phenotypes with in-hospital and 1-year mortality.

Main Methods:

  • K-means clustering was applied to 1498 CS patients using admission laboratory values.
  • Patients were categorized into three clusters: noncongested, cardiorenal, and hemometabolic.
  • Logistic regression and Cox proportional-hazards models analyzed mortality outcomes.

Main Results:

  • Three distinct CS phenotypes (noncongested, cardiorenal, hemometabolic) were identified in 1498 CICU patients.
  • The hemometabolic cluster (Cluster 3) exhibited the greatest illness severity and significantly higher in-hospital mortality (aOR 2.6 vs. Cluster 1).
  • A clear incremental gradient in 1-year mortality was observed across the clusters (Cluster 3 > Cluster 2 > Cluster 1).

Conclusions:

  • The study successfully validated distinct CS phenotypes in a mixed CICU population.
  • These identified phenotypes demonstrate a mortality gradient, offering improved risk stratification for CS patients.
  • Clinical identification of these phenotypes can enhance patient management and outcomes beyond standard risk assessment tools.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
52
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
65
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
103
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
38
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
57